| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/26/2000 | CN1261286A CD154 blockade therapy for pancreatin islet tissue transplantation |
| 07/26/2000 | CN1261285A CD 154 blockade therapy for therapeutic protein inhibitor syndrome |
| 07/26/2000 | CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 07/26/2000 | CN1261282A Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 07/26/2000 | CN1261281A Peptide parathyroid hormone analogs |
| 07/26/2000 | CN1261280A Improved methods for processing activated protein C |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/26/2000 | CN1261275A Method and compositions for administering taxanes orally to human patients |
| 07/26/2000 | CN1261271A Stable pharmaceutical administration forms of peptides, proteins and nucleic acids |
| 07/26/2000 | CN1260997A Medicine for treating male sterility and weak sperm disease |
| 07/26/2000 | CN1054857C Motilin-like polypeptides with gastrointinal motor stimulating activity |
| 07/26/2000 | CN1054775C Method for treating hepatitis B carriers with minimal disease |
| 07/26/2000 | CA2260454A1 Cross-linked oxygen binding proteins |
| 07/25/2000 | US6093816 For transfecting nucleic acids, proteins, oligonucleotides or peptides into prokaryotic or eukaryotic cells by forming a complex with polyanions; toxicity to the cells; nontoxic; drug delivery; antitumor-, carcinogenic agents; fungicides |
| 07/25/2000 | US6093809 Nucleotide sequence; anticarcinogenic and antiaging agents; diagnostic applications; evolutionary (e.g., phylogenetic) investigations |
| 07/25/2000 | US6093804 Method for purification of alpha-1 proteinase inhibitor |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093801 Recombinant analogs of bactericidal/permeability increasing protein |
| 07/25/2000 | US6093800 Amino acid sequence of cell surface protein; diagnostic markers of cancer, including hormone refractory prostate cancer; anticarcinogenic agents |
| 07/25/2000 | US6093797 Modifications of the tripeptide hormone melanocyte stimulating inhibitory factor; can cross blood-brain barrier; side effect reduction |
| 07/25/2000 | US6093796 Recombinant hK2 polypeptide |
| 07/25/2000 | US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells |
| 07/25/2000 | US6093741 Agents with leukotriene B4-like activity as antiherpes viral agents |
| 07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 07/25/2000 | US6093700 Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF |
| 07/25/2000 | US6093699 Method for gene therapy involving suppression of an immune response |
| 07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases |
| 07/25/2000 | US6093694 Antitumor active substances |
| 07/25/2000 | US6093693 B cell activation |
| 07/25/2000 | US6093692 Method and compositions for lipidization of hydrophilic molecules |
| 07/25/2000 | US6093567 Gene therapy for cystic fibrosis |
| 07/25/2000 | US6093565 Nucleotide sequence; hybridization probes; antisense agents; for diagnosis and treatment of immunological disorders (immunosuppresants, autoimmune disorders) and nervous system disorders (alzheimer's disease); anticarcinogenic agents |
| 07/25/2000 | US6093564 Methods and compositions for the selective modification of nucleic acids |
| 07/25/2000 | US6093563 Chondroitin lyase enzymes |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093560 The polypeptide has ability to induce cell cycle arrest; being activated by oxidant stress not by epidermal growth factor, platelet-derived growth factor (pdgf), tumor necrosis factor-alpha, anisomycin, heat shock, or osmolar stress |
| 07/25/2000 | US6093555 Amido and peptido modified enzymatic nucleic acid molecules |
| 07/25/2000 | US6093550 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 07/25/2000 | US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders |
| 07/25/2000 | US6093540 Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor |
| 07/25/2000 | US6093539 Encodes a water-soluble polypeptide of portion of human cd4 glycoprotein able to complex with human immunodeficiency virus envelope glycoprotein; viricides; vaccines |
| 07/25/2000 | US6093405 Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines |
| 07/25/2000 | US6093400 Modified HGP-30 peptides, conjugates, compositions and methods of use |
| 07/25/2000 | US6093399 Specific blood coagulation exemplified by in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody |
| 07/25/2000 | US6093398 Treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction |
| 07/25/2000 | US6093396 Modified glutamic acid decarboxylase (GAD) |
| 07/25/2000 | US6093395 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production |
| 07/25/2000 | US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts |
| 07/25/2000 | US6093392 Comprising a recombinant adeno-associated viral vector |
| 07/25/2000 | US6093391 Peptide compositions containing polyoxyethylene-polyoxypropylene block copolymers that are useful in treatment of diseases and disorders with reduced side effects, ease in administering to desired target site, |
| 07/25/2000 | US6093390 Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor |
| 07/25/2000 | US6093381 Combining chemotherapeutic agent with lymph node lymphocytes which have been cultured under mitogenic stimulation conditions, or supernatant of it enriched in tumor reactive cells, administering such combination to the cancer patient |
| 07/25/2000 | US6092764 Interface seal for an aircraft |
| 07/25/2000 | CA2286314A1 Human tumor suppressor gene |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2094611C Hiv immunotherapeutics |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/25/2000 | CA1341060C Use of amylin agonists in the treatment of diabetes mellitus |
| 07/20/2000 | WO2000042201A2 Human peptidases |
| 07/20/2000 | WO2000042198A1 An e. coli protein tyrosine kinase and its uses |
| 07/20/2000 | WO2000042193A1 Neisseria meningitidis antigen |
| 07/20/2000 | WO2000042189A1 Interleukin-20 |
| 07/20/2000 | WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042187A1 Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042186A1 NOVEL INTERFERON-$g(a) |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042178A2 Antagonist blockade of crf2 receptors for the treatment of psy chiatric disorders and the use of chimeric antisense oligonucleotides in in vivo cns studies of gene function |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042173A1 Catalytic molecules |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042165A2 Bone marrow-specific protein |
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042072A2 Polypeptide variants with altered effector function |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042070A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | WO2000042069A1 Bone stimulating factor |
| 07/20/2000 | WO2000042067A1 Saccharides linked to compounds that bind cell-surface peptides or proteins |
| 07/20/2000 | WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 07/20/2000 | WO2000042065A1 Pseudopeptide, synthesis method, reagent and applications |
| 07/20/2000 | WO2000042064A1 Peptides for inhibiting hpv e6 proteins |
| 07/20/2000 | WO2000042063A2 Peptides for inhibiting hbv core proteins |
| 07/20/2000 | WO2000042062A1 Novel depsipeptide compound |
| 07/20/2000 | WO2000042060A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042050A1 Sulfated phosphatidylinositols, their preparation and use |
| 07/20/2000 | WO2000041740A2 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | WO2000041724A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | WO2000041719A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
| 07/20/2000 | WO2000041717A2 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | WO2000041716A1 New use of melagatran |
| 07/20/2000 | WO2000041713A2 Composition and method for improving function of embryonic kidney transplants |
| 07/20/2000 | WO2000041712A1 Inhibiting development of microvessels within vascular walls |
| 07/20/2000 | WO2000041711A1 Methods for inhibiting tumor metastasis, and peptides useful therefor |
| 07/20/2000 | WO2000041710A1 Glycopeptide antibiotics containing a desmethylvancosamine residue, combinatorial libraries of same and methods of producing same |
| 07/20/2000 | WO2000041685A1 Ccr-3 receptor antagonists |
| 07/20/2000 | WO2000041682A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 07/20/2000 | WO2000041677A1 Granules for oral administration, process for producing the same, and tablets produced from the granules |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |